| The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine S Bayda, M Adeel, T Tuccinardi, M Cordani, F Rizzolio Molecules 25 (1), 112, 2020 | 1441 | 2020 |
| Inorganic Nanoparticles for Cancer Therapy: a Transition from Lab to Clinic. S Bayda, M Hadla, S Palazzolo, P Riello, G Corona, G Toffoli, F Rizzolio Current Medicinal Chemistry 25 (34), 4269 - 4303, 2018 | 200 | 2018 |
| DNA Nanotechnology for Cancer Therapy V Kumar, S Palazzolo, S Bayda, G Corona, G Toffoli, F Rizzolio Theranostics 6 (5), 710-725, 2016 | 170 | 2016 |
| The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes S Palazzolo, S Bayda, M Hadla, I Caligiuri, G Corona, G Toffoli, F Rizzolio Current Medicinal Chemistry 25 (34), 4224 - 4268, 2018 | 158 | 2018 |
| Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy S Bayda, M Hadla, S Palazzolo, V Kumar, I Caligiuri, E Ambrosi, ... Journal of Controlled Release 248, 144-152, 2017 | 69 | 2017 |
| Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin S Palazzolo, M Hadla, C Russo Spena, S Bayda, V Kumar, F Lo Re, ... ACS Medicinal Chemistry Letters 10 (4), 517-521, 2019 | 43 | 2019 |
| Carbon Dots for Cancer Nanomedicine: A Bright Future S Bayda, E Amadio, S Cailotto, Y Frión-Herrera, A Perosa, F Rizzolio Nanoscale Advances 3 (18), 5183-5221, 2021 | 41 | 2021 |
| Enhanced Chemotherapeutic Behavior of Open‐Caged DNA@ Doxorubicin Nanostructures for Cancer Cells V Kumar, S Bayda, M Hadla, I Caligiuri, CR Spena, S Palazzolo, ... Journal of Cellular Physiology 231 (1), 106-110, 2016 | 37 | 2016 |
| Synthesis and characterization of new chiral P, O ferrocenyl ligands and catalytic application to asymmetric Suzuki–Miyaura coupling S Bayda, A Cassen, JC Daran, C Audin, R Poli, E Manoury, E Deydier Journal of Organometallic Chemistry 772, 258-264, 2014 | 26 | 2014 |
| Synthesis of fluorescent carbon nanoparticles (CNPs) and their applications in drug delivery S Bayda Università degli Studi di Trieste, 2017 | 1 | 2017 |
| Acknowledgment to Reviewers of Cancers in 2020 C Abad, SF Adams, ML Abba, DC Adamson, C Abbondanza, S Adeberg, ... | | 2021 |
| First Italian-Lebanese Science Day “Global Science” IF Hall | | 2019 |
| Novel DNA origami structure for Doxorubicin delivery S Palazzolo, M Hadla, C Russo Spena, S Bayda, G Corona, G Toffoli, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy P RIELLO, S BAYDA, E PONTOGLIO, G TOFFOLI, S PALAZZOLO | | |
| Enhanced Chemotherapeutic Behavior of Open-Caged DNA@ Doxorubicin Nanostructures for Cancer Cells S PALAZZOLO, S BAYDA | | |
| DNA Nanotechnology for Cancer Therapy G TOFFOLI, S BAYDA, S PALAZZOLO | | |
Tiziano TuccinardiAssociate Professor, University of PisaVerified email at unipi.it
